MYC and prostate carcinoma: Using Hi-Myc derived RON overexpressing prostate cancer cells; our laboratory demonstrated that macrophage depletion, via clodronate treatment, significantly decreased prostate tumor growth similar to pharmacological RON inhibition [39].